| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Tyrosinase (146-156)??;SSDYVIPIGTY |
|
|
詳細
|
| Tyrosinase (206-214), T9206??;AFLPWHRLF |
|
|
詳細
|
| Tyrosinase (240-251)??;DAEKCDICTDEY |
|
|
詳細
|
| Tyrosinase (450-462)??;SYLQDSDPDSFQD |
|
|
詳細
|
| Tyrosinase (56–70)??;QNILLSNAPLGPQFP |
|
|
詳細
|
| Tyrosinase(243-251),core nonamer sequence??;KCDICTDEY |
|
|
詳細
|
| Tyrosine Hydroxylase 24-33 [KQAEAVTSPR], 5-FAM labeled;5-FAM-KQAEAVTSPR |
|
|
詳細
|
| Tyrosine Hydroxylase 24-33 [KQAEAVTSPR], 5-TMR labeled;5-TMR-KQAEAVTSPR |
|
|
詳細
|
| Tyrosine Hydroxylase 24-33 [KQAEAVTSPR], Biotinylated;Biotin-KQAEAVTSPR |
|
|
詳細
|
| Tyrosine Hydroxylase 24-33 [KQAEAVTSPR];KQAEAVTSPR |
|
|
詳細
|
| Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], 5-FAM labeled;5-FAM-KVEKIGEGTYGVVYK |
|
|
詳細
|
| Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], 5-TMR labeled;5-TMR-KVEKIGEGTYGVVYK |
TYROSINE KINASE PEPTIDE 1 [KVEKIGEGTYGVVYK], 5-TMR LABELED |
|
詳細
|
| Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], Bioyinylated;Biotin-KVEKIGEGTYGVVYK |
|
|
詳細
|
| Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK];KVEKIGEGTYGVVYK |
TYROSINE KINASE PEPTIDE 1 |
|
詳細
|
| Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Amide, Phosphorylated, Biotinylated;Biotin-RRLIEDAE-pY-AARG-NH2 |
|
|
詳細
|
| Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Amide, Phosphorylated;RRLIEDAE-pY-AARG-NH2 |
|
|
詳細
|
| Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Phosphorylated;RRLIEDAE-pY-AARG |
TYROSINE KINASE PEPTIDE 3 [RRLIEDAE-PY-AARG], PHOSPHORYLATED |
|
詳細
|
| Tyrosine Kinase Peptide 3 [RRLIEDAEYAARG], Biotinylated;Biotin-RRLIEDAEYAARG |
BIOTIN-ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-TYR-ALA-ALA-ARG-GLY-OH |
|
詳細
|
| UOM9, PKC Substrate, phosphorylated;KRP-pS-QRHGSKY-NH2 |
UOM9, PKC SUBSTRATE, PHOSPHORYLATED |
|
詳細
|
| Urotensin II, rat: [pGlu110]-Prepro-Urotensin II (110-123), rat;Pyr-HGTAPECFWKYCI(Disulfidebridge:8-13) |
UROTENSIN II, RAT; [PYR110]-PREPRO-UROTENSIN II (110-123), RAT |
|
詳細
|
| VEGFR2/KDR Antagonist;ATWLPPR |
ATWLPPR |
|
詳細
|
| VIP, human, porcine, rat, FAM-labeled;FAM-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 |
VIP, HUMAN, PORCINE, RAT, FAM-LABELED |
|
詳細
|
| VIP-Lys(Biotin), human, porcine, rat, FAM-labeled;FAM-HSDAVFTDNYTRLRKQMAVKKYLNSILNK(Biotin)-NH2 |
|
|
詳細
|
| VSV(52-59)??;RGYGYQGL |
|
|
詳細
|
| WAAG-3R;Abz-TEGEARGSVI-Dap(Dnp)-KK-NH2 |
生物活性肽WAAG-3R |
|
詳細
|
| WKYMVm-NH2;WKYMVm-NH2 |
WKYMVM-NH2 |
|
詳細
|
| Z-Arg-Gly-Phe-Phe-Leu-AFC;Z-RGFFL-AFC |
Z-ARG-GLY-PHE-PHE-LEU-AFC |
|
詳細
|
| Z-Gly-Gly-Arg-AFC;Z-GGR-AFC |
Z-GLY-GLY-ARG-AFC |
|
詳細
|
| Z-Val-Lys-Lys-Arg-AFC;Z-VKKR-AFC |
Z-VAL-LYS-LYS-ARG-AFC |
|
詳細
|
| α3β1 Integrin Peptide Fragment (325), amide;PRHRHMGAVFLLSQEAG-NH2 |
ALPHA3BETA1 INTEGRIN PEPTIDE FRAGMENT (325), AMIDE |
|
詳細
|
| α-Calcitonin Gene Related Peptide, α-CGRP, rat;SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2(Disulfidebridge:2-7) |
|
|
詳細
|
| cyclo(Arg-Gly-Asp-D-Phe-Lys(Mpa)) |
CYCLO(ARG-GLY-ASP-D-PHE-LYS(MPA)) |
|
詳細
|
| cyclo [Arg-Gly-Asp-d-Phe-Lys(Biotin)] |
CYCLO [ARG-GLY-ASP-D-PHE-LYS(BIOTIN)] |
|
詳細
|
| E-[cyclo(RGDfK)2 |
E-[CYCLO(RGDFK)2 |
|
詳細
|
| CYCLO(ARG-GLY-ASP-D-Tyr-LYS(COCH2SH)) |
CYCLO(ARG-GLY-ASP-D-Tyr-LYS(巰基乙酸)) |
|
詳細
|
| Fmoc-Val-Thr{psi(Me,Me)pro}-OH |
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2,5-三甲基-4-惡唑烷羧酸 |
168216-05-5 |
詳細
|
| Liraglutide /Liraglutide Acetate |
利拉魯肽/醋酸利拉魯肽 |
204656-20-2 |
詳細
|
| Endotoxin Substrate;Boc-Leu-Gly-Arg-pNA |
鱟試劑三肽 |
68223-96-1 |
詳細
|
| CYCLO(ARG-GLY-ASP-D-Tyr-LYS(Mpa)) |
CYCLO(RGDyK(mpa));CYCLO(RGDyK(巰基丙酸)) |
|
詳細
|
| CYCLO(ARG-GLY-ASP-D-Tyr-LYS(COCH2CH2SH)) |
CYCLO(ARG-GLY-ASP-D-TYR-LYS(COCH2CH2SH)) |
|
詳細
|
| cyclo (Arg-Gly-Asp-d-Tyr-Lys(Biotin));c(RGDyK(Biotin));cyclo(RGDYK(Biotin)) |
CYCLO (ARG-GLY-ASP-D-TYR-LYS(BIOTIN));C(RGDYK(BIOTIN));CYCLO(RGDYK(BIOTIN)) |
|
詳細
|
| BOC-GLY-OME |
BOC-甘氨酸甲酯 |
31954-27-5 |
詳細
|
| bursin trihydrochloride;LYS-HIS-GLY-NH2 80+%;L-Lysyl-L-histidylglycinaMide trihydrochloride |
L-賴氨酰-L-組氨酰甘氨酰胺三鹽酸鹽 |
112898-17-6 |
詳細
|
| Tertiapin-Q |
TERTIAPIN-Q |
252198-49-5 |
詳細
|
| linaclotide |
利那洛肽 |
851199-59-2 |
詳細
|
| Dalargin,(D-Ala2)-Leu-Enkephalin-Arg;H-Tyr-D-Ala-Gly-Phe-Leu-Arg-OH |
DALARGIN |
81733-79-1 |
詳細
|
| FMOC-LYS(ME3)-OH HCL |
N-芴甲氧羰基-N',N',N'-三甲基-L-賴氨酸鹽酸鹽 |
201004-29-7 |
詳細
|
| FMOC-LYS(ME)2-OH HCL |
N-芴甲氧羰基-N',N'-二甲基-L-賴氨酸鹽酸鹽 |
252049-10-8 |
詳細
|
| Fmoc-Ala-Thr{psi(Me,Me)pro}-OH |
(4S,5R)-3-(N-芴甲氧羰基丙氨酰)-2,2,5-三甲基惡唑烷-4-羧酸 |
252554-79-3 |
詳細
|
| Fmoc-Asn(Trt)-Ser{psi(Me,Me)pro}-OH |
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2-二甲基-4-惡唑烷羧酸 |
920519-33-1 |
詳細
|
| Fmoc-Asn(Trt)-Thr{psi(Me,Me)pro}-OH |
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2,5-三甲基-4-惡唑烷羧酸 |
957780-59-5 |
詳細
|
| Fmoc-Asp(OtBu)-Ser{psi(Me,Me)pro}-OH |
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-惡唑烷丁酸叔丁酯 |
955048-92-7 |
詳細
|
| Fmoc-Asp(OtBu)-Thr{psi(Me,Me)pro}-OH |
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2,5-三甲基-GAMMA-氧代-3-惡唑烷丁酸叔丁酯 |
920519-32-0 |
詳細
|
| Fmoc-Gln(Trt)-Ser{psi(Me,Me)pro}-OH |
FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH |
1821378-64-6 |
詳細
|
| Fmoc-Gln(Trt)-Thr{psi(Me,Me)pro}-OH |
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,5-二氧代-5-[(三苯基甲基)氨基]戊基]-2,2,5-三甲基-4-惡唑烷羧酸 |
1572725-72-4 |
詳細
|
| Fmoc-Glu(OtBu)-Ser{psi(Me,Me)pro}-OH |
(GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-惡唑烷戊酸叔丁酯 |
909115-33-9 |
詳細
|
| Fmoc-Glu(OtBu)-Thr{psi(Me,Me)pro}-OH |
(4S)-3-[2-[[芴甲氧羰基]氨基]乙?；鵠-2,2-二甲基-4-惡唑烷羧酸 |
1095952-22-9 |
詳細
|
| Fmoc-Gly-Ser{psi(Me,Me)pro}-OH |
FMOC-GLY-SER(PSI(ME,ME)PRO)-OH |
1095952-22-9 |
詳細
|
| Fmoc-Gly-Thr{psi(Me,Me)pro}-OH |
(4S,5R)-3-[2-[[芴甲氧羰基]氨基]乙?；鵠-2,2,5-三甲基-4-惡唑烷羧酸 |
1262308-49-5 |
詳細
|
| Fmoc-Ile-Ser{psi(Me,Me)pro}-OH |
(4S)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2-二甲基-4-惡唑烷羧酸 |
1147996-34-6 |
詳細
|
| Fmoc-Ile-Thr{psi(Me,Me)pro}-OH |
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2-二甲基-4-惡唑烷羧酸 |
339531-50-9 |
詳細
|
| Fmoc-Leu-Ser{psi(Me,Me)pro}-OH |
FMOC-LEU-SER(PSI(ME,ME)PRO)-OH |
|
詳細
|
| Fmoc-Leu-Thr{psi(Me,Me)pro}-OH |
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-惡唑烷羧酸 |
955048-89-2 |
詳細
|
| Fmoc-Lys(Boc)-Ser{psi(Me,Me)pro}-OH |
(4S,5R)-3-[(2S)-6-[[叔丁氧羰基]氨基]-2-[[芴甲氧羰基]氨基]-1-氧代己基]-2,2,5-三甲基-4-惡唑烷羧酸 |
911838-56-7 |
詳細
|
| Fmoc-Phe-Ser{psi(Me,Me)pro}-OH |
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2-二甲基-4-惡唑烷羧酸 |
878797-01-4 |
詳細
|
| Fmoc-Phe-Thr{psi(Me,Me)pro}-OH |
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2,5-三甲基-4-惡唑烷羧酸 |
1196703-48-6 |
詳細
|
| Fmoc-Ser(tBu)-Ser{psi(Me,Me)pro}-OH |
D-絲氨酸偽二肽 |
1000164-43-1 |
詳細
|
| ω-Conotoxin MVIIA;CKGKGAKCSRLMYDCCTGSCRSGKC-NH2(Disulfidebridge:1-16,8-20,and15-25) |
齊考諾肽 |
107452-89-1 |
詳細
|
| γ-Bag Cell Peptide;RLRFD |
Γ - BAG CELL PEPTIDE |
|
詳細
|
| β-Secretase Substrate 5, Swedish Double Mutation Sequence;[HiLyteFluor?488-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(QXL?520)-OH] |
|
|
詳細
|
| β-catenin peptide, (βCATp)??NEW;RTYTYEKL |
|
|
詳細
|
| α-MSH, amide;Ac-SYSMEHFRWGKPV-NH2 |
垂體中葉素 |
9061-59-0 |
詳細
|
| TRP-2 coding region fragment??;LLPGGRPYR |
|
|
詳細
|
| Fmoc-Ser(tBu)-Thr{psi(Me,Me)pro}-OH |
(4S,5R)-3-[(2S)-3-(叔丁氧基)-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-惡唑烷羧酸 |
1266350-99-5 |
詳細
|
| Fmoc-Trp(Boc)-Ser{psi(Me,Me)pro}-OH |
3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-惡唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯 |
908601-15-0 |
詳細
|
| Fmoc-Tyr(tBu)-Ser{psi(Me,Me)pro}-OH |
(4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-惡唑烷羧酸 |
878797-09-2 |
詳細
|
| Fmoc-Tyr(tBu)-Thr{psi(Me,Me)pro}-OH |
(4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-惡唑烷羧酸 |
920519-31-9 |
詳細
|
| cyclo (Arg-Ala-Asp-Tyr-Val) |
CYCLO (RADYV) |
|
詳細
|
| cyclo (Arg-Ala-Asp-Phe-Glu) |
CYCLO (RADFE) |
|
詳細
|
| cyclo (Arg-Ala-Asp-Tyr-Glu) |
CYCLO (RADYE) |
|
詳細
|
| cyclo (Arg-Ala-Asp-Tyr-Lys) |
cyclo (Arg-Ala-Asp-Tyr-Lys) |
1193347-53-3 |
詳細
|
| cyclo (Arg-Ala-Asp-Phe-Cys) |
CYCLO (RADFC) |
|
詳細
|
| cyclo (Arg-Ala-Asp-Phe-Val) |
CYCLO (RADFV) |
|
詳細
|
| cyclo (Arg-Ala-Asp-Phe-Lys) |
CYCLO (RADFK) |
|
詳細
|
| cyclo (Arg-Ala-Asp-Tyr-Cys) |
CYCLO (RADYC) |
|
詳細
|
| cyclo (Arg-Gly-Asp-D-Tyr-Cys) |
CYCLO (RGDYC) |
|
詳細
|
| cyclo (Arg-Gly-Asp-Tyr-Glu) |
CYCLO (RGDYE) |
|
詳細
|
| cyclo (Arg-Gly-Asp-Tyr-Val) |
CYCLO (RGDYV) |
|
詳細
|
| cyclo (Arg-Gly-Asp-Phe-Cys) |
CYCLO (RGDFC) |
|
詳細
|
| cyclo (Arg-Gly-Asp-Phe-Glu) |
CYCLO (RGDFE) |
|
詳細
|
| cyclo (Arg-Gly-Asp-Phe-Val) |
CYCLO (RGDFV) |
|
詳細
|
| cyclo (Arg-Gly-Asp-Tyr-Cys) |
CYCLO (RGDYS) |
|
詳細
|
| SALUSIN-ALPHA (HUMAN) |
SALUSIN-ALPHA (HUMAN) |
624735-22-4 |
詳細
|
| H-Glu[cyclo (Arg-Gly-Asp-d-Tyr-Lys)]2 |
H-GLU[CYCLO (ARG-GLY-ASP-D-TYR-LYS)]2 |
|
詳細
|
| E-[C(RGDFK)2];H-GLU(CYCLO(ARG-GLY-ASP-D-PHE-LYS))2 |
E-[C(RGDFK)2] |
2377091-64-8 |
詳細
|
| cyclo (Arg-Ala-Asp-d-Phe-Cys) |
CYCLO (ARG-ALA-ASP-D-PHE-CYS) |
1055991-02-0 |
詳細
|
| cyclo (Arg-Ala-Asp-d-Phe-Lys) |
整合素配體多肽Cyclo(Arg-Ala-Asp-d-Phe-Lys） |
756500-23-9 |
詳細
|
| cyclo (Arg-Ala-Asp-d-Tyr-Cys) |
CYCLO (ARG-ALA-ASP-D-TYR-CYS) |
|
詳細
|
| cyclo (Arg-Gly-Asp-d-Phe-Cys) |
CYCLO (ARG-GLY-ASP-D-PHE-CYS) |
862772-11-0 |
詳細
|
| cyclo (Arg-Gly-Asp-d-Phe-Glu) |
cyclo (Arg-Gly-Asp-d-Phe-Glu) |
756500-22-8 |
詳細
|